Incentives for COVID-19 vaccination

• Noel T. Brewer,
• Alison M. Buttenheim,
• Chelsea V. Clinton,
• Michelle M. Mello,
• Regina M. Benjamin,
• Timothy Callaghan,
• Arthur Caplan,
• Richard M. Carpiano,
• Renee DiResta,
• Jad A. Elharake,
• Lisa C. Flowers,
• Alison P. Galvani,
• Peter J. Hotez,
• Rekha Lakshmanan,
• Yvonne A. Maldonado,
• Saad B. Omer,
• Daniel A. Salmon,
• Jason L. Schwartz,
• Joshua M. Sharfstein,
• Douglas J. Opel

Affiliations

Noel T. Brewer

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, 325 Rosenau Hall CB7440, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; Corresponding author at: Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, 325 Rosenau Hall CB7440, Chapel Hill, NC 27599, USA.

Alison M. Buttenheim

Department of Family and Community Health, University of Pennsylvania School of Nursing, and Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA, USA

Chelsea V. Clinton

Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, NY, USA; Clinton Foundation, New York, NY, USA

Michelle M. Mello

Stanford Law School and Stanford School of Medicine, Stanford University, USA; Department of Health Policy, Stanford University School of Medicine, Stanford, CA, USA; Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA

Regina M. Benjamin

Gulf States Health Policy Center, Bayou La Batre, AL, USA

Timothy Callaghan

Department of Health Policy and Management, School of Public Health, Texas A&M University, College Station, TX, USA

Arthur Caplan

New York University Langone School of Medicine, New York University, New York, NY, USA

Richard M. Carpiano

School of Public Policy, University of California, Riverside, CA, USA

Renee DiResta

Stanford Internet Observatory, Stanford University, Stanford, CA, USA

Jad A. Elharake

Yale Institute for Global Health, New Haven, CT, USA; Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, USA

Lisa C. Flowers

Department of Obstetrics and Gynecology, Emory University, Atlanta, Georgia, USA.

Alison P. Galvani

Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA

Peter J. Hotez

Texas Children's Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, USA; James A Baker III Institute for Public Policy, Rice University, Houston, TX, USA; Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, TX, USA

Rekha Lakshmanan

The Immunization Partnership, Houston, TX, USA

Yvonne A. Maldonado

Stanford University School of Medicine, Stanford, CA, USA

Saad B. Omer

Yale Institute for Global Health, New Haven, CT, USA; Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, USA; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; Yale School of Nursing, Orange, CT, USA

Daniel A. Salmon

Department of International Health, Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA

Jason L. Schwartz

Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA

Joshua M. Sharfstein

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

Douglas J. Opel

Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA; Seattle Children's Research Institute, Seattle, WA, USA